nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—UGT2B7—urinary bladder cancer	0.485	1	CbGaD
Pitavastatin—UGT2B7—Epirubicin—urinary bladder cancer	0.0446	0.12	CbGbCtD
Pitavastatin—ABCB1—Mitomycin—urinary bladder cancer	0.029	0.078	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0236	0.0635	CbGbCtD
Pitavastatin—ABCC2—Carboplatin—urinary bladder cancer	0.0217	0.0586	CbGbCtD
Pitavastatin—ABCG2—Fluorouracil—urinary bladder cancer	0.0198	0.0533	CbGbCtD
Pitavastatin—ABCG2—Carboplatin—urinary bladder cancer	0.0197	0.053	CbGbCtD
Pitavastatin—ABCC2—Cisplatin—urinary bladder cancer	0.0186	0.0501	CbGbCtD
Pitavastatin—ABCC2—Etoposide—urinary bladder cancer	0.0183	0.0492	CbGbCtD
Pitavastatin—ABCG2—Cisplatin—urinary bladder cancer	0.0168	0.0453	CbGbCtD
Pitavastatin—ABCG2—Etoposide—urinary bladder cancer	0.0165	0.0445	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0137	0.037	CbGbCtD
Pitavastatin—ALB—Fluorouracil—urinary bladder cancer	0.0136	0.0367	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—urinary bladder cancer	0.0125	0.0336	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—urinary bladder cancer	0.0121	0.0325	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—urinary bladder cancer	0.0113	0.0303	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—urinary bladder cancer	0.0109	0.0294	CbGbCtD
Pitavastatin—CYP2C8—Fluorouracil—urinary bladder cancer	0.0105	0.0284	CbGbCtD
Pitavastatin—CYP2C8—Etoposide—urinary bladder cancer	0.00879	0.0237	CbGbCtD
Pitavastatin—ABCB1—Gemcitabine—urinary bladder cancer	0.00834	0.0225	CbGbCtD
Pitavastatin—ALB—Methotrexate—urinary bladder cancer	0.00752	0.0203	CbGbCtD
Pitavastatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.00735	0.0198	CbGbCtD
Pitavastatin—CYP2C9—Cisplatin—urinary bladder cancer	0.00624	0.0168	CbGbCtD
Pitavastatin—ABCB1—Cisplatin—urinary bladder cancer	0.00606	0.0163	CbGbCtD
Pitavastatin—ABCB1—Etoposide—urinary bladder cancer	0.00595	0.016	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—urinary bladder cancer	0.00406	0.0109	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—urinary bladder cancer	0.00393	0.0106	CbGbCtD
Pitavastatin—Fluvastatin—UGT2B7—urinary bladder cancer	0.00201	0.534	CrCbGaD
Pitavastatin—Memory loss—Fluorouracil—urinary bladder cancer	0.00179	0.0343	CcSEcCtD
Pitavastatin—Atorvastatin—UGT2B7—urinary bladder cancer	0.00175	0.466	CrCbGaD
Pitavastatin—SLC10A1—prostate gland—urinary bladder cancer	0.00172	0.0534	CbGeAlD
Pitavastatin—Memory loss—Cisplatin—urinary bladder cancer	0.0017	0.0325	CcSEcCtD
Pitavastatin—UGT2B7—prostate gland—urinary bladder cancer	0.00161	0.0501	CbGeAlD
Pitavastatin—CYP2C9—urine—urinary bladder cancer	0.0016	0.0498	CbGeAlD
Pitavastatin—Cognitive disorder—Thiotepa—urinary bladder cancer	0.00147	0.0282	CcSEcCtD
Pitavastatin—SLC10A1—seminal vesicle—urinary bladder cancer	0.00145	0.0452	CbGeAlD
Pitavastatin—HMGCR—prostate gland—urinary bladder cancer	0.00119	0.037	CbGeAlD
Pitavastatin—SLC10A1—renal system—urinary bladder cancer	0.00117	0.0364	CbGeAlD
Pitavastatin—UGT2B7—renal system—urinary bladder cancer	0.0011	0.0341	CbGeAlD
Pitavastatin—ORM1—prostate gland—urinary bladder cancer	0.00105	0.0327	CbGeAlD
Pitavastatin—Cognitive impairment—Methotrexate—urinary bladder cancer	0.00105	0.0201	CcSEcCtD
Pitavastatin—SLCO2B1—prostate gland—urinary bladder cancer	0.00101	0.0313	CbGeAlD
Pitavastatin—HMGCR—seminal vesicle—urinary bladder cancer	0.001	0.0313	CbGeAlD
Pitavastatin—SLCO1B3—vagina—urinary bladder cancer	0.000971	0.0302	CbGeAlD
Pitavastatin—SLC10A1—female reproductive system—urinary bladder cancer	0.000937	0.0292	CbGeAlD
Pitavastatin—UGT2B7—female reproductive system—urinary bladder cancer	0.000878	0.0273	CbGeAlD
Pitavastatin—HMGCR—epithelium—urinary bladder cancer	0.000872	0.0272	CbGeAlD
Pitavastatin—ABCC2—prostate gland—urinary bladder cancer	0.000862	0.0269	CbGeAlD
Pitavastatin—HMGCR—smooth muscle tissue—urinary bladder cancer	0.000841	0.0262	CbGeAlD
Pitavastatin—Memory impairment—Thiotepa—urinary bladder cancer	0.00081	0.0155	CcSEcCtD
Pitavastatin—HMGCR—renal system—urinary bladder cancer	0.000809	0.0252	CbGeAlD
Pitavastatin—HMGCR—urethra—urinary bladder cancer	0.000795	0.0248	CbGeAlD
Pitavastatin—Back pain—Valrubicin—urinary bladder cancer	0.000776	0.0149	CcSEcCtD
Pitavastatin—SLCO1B1—renal system—urinary bladder cancer	0.000775	0.0241	CbGeAlD
Pitavastatin—Interstitial lung disease—Gemcitabine—urinary bladder cancer	0.000756	0.0145	CcSEcCtD
Pitavastatin—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.000745	0.0143	CcSEcCtD
Pitavastatin—Malaise—Valrubicin—urinary bladder cancer	0.000724	0.0139	CcSEcCtD
Pitavastatin—SLCO2B1—renal system—urinary bladder cancer	0.000686	0.0214	CbGeAlD
Pitavastatin—Myalgia—Valrubicin—urinary bladder cancer	0.000683	0.0131	CcSEcCtD
Pitavastatin—Discomfort—Valrubicin—urinary bladder cancer	0.000675	0.0129	CcSEcCtD
Pitavastatin—HMGCR—female reproductive system—urinary bladder cancer	0.000648	0.0202	CbGeAlD
Pitavastatin—Interstitial lung disease—Etoposide—urinary bladder cancer	0.000646	0.0124	CcSEcCtD
Pitavastatin—Cognitive disorder—Methotrexate—urinary bladder cancer	0.000633	0.0121	CcSEcCtD
Pitavastatin—ABCG2—prostate gland—urinary bladder cancer	0.000629	0.0196	CbGeAlD
Pitavastatin—SLCO1B1—female reproductive system—urinary bladder cancer	0.000621	0.0193	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.000597	0.0114	CcSEcCtD
Pitavastatin—ABCC2—renal system—urinary bladder cancer	0.000588	0.0183	CbGeAlD
Pitavastatin—HMGCR—vagina—urinary bladder cancer	0.000586	0.0183	CbGeAlD
Pitavastatin—ORM1—female reproductive system—urinary bladder cancer	0.000573	0.0178	CbGeAlD
Pitavastatin—SLCO2B1—female reproductive system—urinary bladder cancer	0.000549	0.0171	CbGeAlD
Pitavastatin—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00054	0.0104	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.000536	0.0103	CcSEcCtD
Pitavastatin—ABCG2—seminal vesicle—urinary bladder cancer	0.000532	0.0166	CbGeAlD
Pitavastatin—Myositis—Epirubicin—urinary bladder cancer	0.000522	0.01	CcSEcCtD
Pitavastatin—Abdominal pain—Valrubicin—urinary bladder cancer	0.000518	0.00993	CcSEcCtD
Pitavastatin—Hepatic failure—Thiotepa—urinary bladder cancer	0.000514	0.00985	CcSEcCtD
Pitavastatin—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.000513	0.00984	CcSEcCtD
Pitavastatin—Malaise—Mitomycin—urinary bladder cancer	0.000499	0.00956	CcSEcCtD
Pitavastatin—Myositis—Doxorubicin—urinary bladder cancer	0.000483	0.00927	CcSEcCtD
Pitavastatin—ABCC2—female reproductive system—urinary bladder cancer	0.000471	0.0147	CbGeAlD
Pitavastatin—Asthenia—Valrubicin—urinary bladder cancer	0.00047	0.00901	CcSEcCtD
Pitavastatin—Discomfort—Mitomycin—urinary bladder cancer	0.000465	0.00892	CcSEcCtD
Pitavastatin—Pruritus—Valrubicin—urinary bladder cancer	0.000463	0.00889	CcSEcCtD
Pitavastatin—Confusional state—Mitomycin—urinary bladder cancer	0.000455	0.00873	CcSEcCtD
Pitavastatin—Diarrhoea—Valrubicin—urinary bladder cancer	0.000448	0.0086	CcSEcCtD
Pitavastatin—CYP2C8—renal system—urinary bladder cancer	0.000441	0.0137	CbGeAlD
Pitavastatin—Dizziness—Valrubicin—urinary bladder cancer	0.000433	0.00831	CcSEcCtD
Pitavastatin—Hepatic failure—Gemcitabine—urinary bladder cancer	0.000432	0.00829	CcSEcCtD
Pitavastatin—ABCG2—urethra—urinary bladder cancer	0.000421	0.0131	CbGeAlD
Pitavastatin—Rash—Valrubicin—urinary bladder cancer	0.000413	0.00792	CcSEcCtD
Pitavastatin—Dermatitis—Valrubicin—urinary bladder cancer	0.000413	0.00791	CcSEcCtD
Pitavastatin—Headache—Valrubicin—urinary bladder cancer	0.00041	0.00787	CcSEcCtD
Pitavastatin—Amnesia—Fluorouracil—urinary bladder cancer	0.000406	0.0078	CcSEcCtD
Pitavastatin—Renal failure acute—Cisplatin—urinary bladder cancer	0.000392	0.00752	CcSEcCtD
Pitavastatin—Nausea—Valrubicin—urinary bladder cancer	0.000389	0.00746	CcSEcCtD
Pitavastatin—Fatigue—Mitomycin—urinary bladder cancer	0.000389	0.00746	CcSEcCtD
Pitavastatin—Interstitial lung disease—Methotrexate—urinary bladder cancer	0.000387	0.00742	CcSEcCtD
Pitavastatin—Amnesia—Cisplatin—urinary bladder cancer	0.000385	0.00739	CcSEcCtD
Pitavastatin—HMGCR—lymph node—urinary bladder cancer	0.000379	0.0118	CbGeAlD
Pitavastatin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000372	0.00713	CcSEcCtD
Pitavastatin—CYP2C8—female reproductive system—urinary bladder cancer	0.000353	0.011	CbGeAlD
Pitavastatin—Jaundice—Thiotepa—urinary bladder cancer	0.000347	0.00665	CcSEcCtD
Pitavastatin—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.000342	0.00655	CcSEcCtD
Pitavastatin—Influenza—Gemcitabine—urinary bladder cancer	0.000336	0.00644	CcSEcCtD
Pitavastatin—ORM1—lymph node—urinary bladder cancer	0.000335	0.0104	CbGeAlD
Pitavastatin—Asthenia—Mitomycin—urinary bladder cancer	0.000324	0.00621	CcSEcCtD
Pitavastatin—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.000324	0.00621	CcSEcCtD
Pitavastatin—SLCO2B1—lymph node—urinary bladder cancer	0.000321	0.01	CbGeAlD
Pitavastatin—CYP2C8—vagina—urinary bladder cancer	0.000319	0.00994	CbGeAlD
Pitavastatin—CYP2C9—female reproductive system—urinary bladder cancer	0.000314	0.00977	CbGeAlD
Pitavastatin—ABCG2—vagina—urinary bladder cancer	0.00031	0.00967	CbGeAlD
Pitavastatin—ABCB1—prostate gland—urinary bladder cancer	0.00031	0.00966	CbGeAlD
Pitavastatin—Diarrhoea—Mitomycin—urinary bladder cancer	0.000309	0.00592	CcSEcCtD
Pitavastatin—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.0003	0.00575	CcSEcCtD
Pitavastatin—Dizziness—Mitomycin—urinary bladder cancer	0.000298	0.00572	CcSEcCtD
Pitavastatin—ALB—lymph node—urinary bladder cancer	0.000294	0.00915	CbGeAlD
Pitavastatin—Rash—Mitomycin—urinary bladder cancer	0.000285	0.00546	CcSEcCtD
Pitavastatin—Dermatitis—Mitomycin—urinary bladder cancer	0.000284	0.00545	CcSEcCtD
Pitavastatin—Headache—Mitomycin—urinary bladder cancer	0.000283	0.00542	CcSEcCtD
Pitavastatin—ABCC2—lymph node—urinary bladder cancer	0.000275	0.00857	CbGeAlD
Pitavastatin—Back pain—Thiotepa—urinary bladder cancer	0.000269	0.00516	CcSEcCtD
Pitavastatin—Nausea—Mitomycin—urinary bladder cancer	0.000268	0.00514	CcSEcCtD
Pitavastatin—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.000263	0.00504	CcSEcCtD
Pitavastatin—ABCB1—seminal vesicle—urinary bladder cancer	0.000262	0.00817	CbGeAlD
Pitavastatin—Jaundice—Etoposide—urinary bladder cancer	0.000249	0.00478	CcSEcCtD
Pitavastatin—Myalgia—Thiotepa—urinary bladder cancer	0.000237	0.00454	CcSEcCtD
Pitavastatin—Arthralgia—Thiotepa—urinary bladder cancer	0.000237	0.00454	CcSEcCtD
Pitavastatin—Confusional state—Thiotepa—urinary bladder cancer	0.000229	0.00439	CcSEcCtD
Pitavastatin—Hypoaesthesia—Etoposide—urinary bladder cancer	0.000228	0.00438	CcSEcCtD
Pitavastatin—ABCB1—epithelium—urinary bladder cancer	0.000228	0.0071	CbGeAlD
Pitavastatin—Back pain—Gemcitabine—urinary bladder cancer	0.000226	0.00434	CcSEcCtD
Pitavastatin—Hepatic failure—Methotrexate—urinary bladder cancer	0.000221	0.00424	CcSEcCtD
Pitavastatin—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000217	0.00416	CcSEcCtD
Pitavastatin—Renal failure acute—Methotrexate—urinary bladder cancer	0.000215	0.00413	CcSEcCtD
Pitavastatin—ABCB1—renal system—urinary bladder cancer	0.000211	0.00658	CbGeAlD
Pitavastatin—Malaise—Gemcitabine—urinary bladder cancer	0.000211	0.00405	CcSEcCtD
Pitavastatin—Muscle spasms—Cisplatin—urinary bladder cancer	0.00021	0.00402	CcSEcCtD
Pitavastatin—ABCB1—urethra—urinary bladder cancer	0.000208	0.00647	CbGeAlD
Pitavastatin—Hepatic failure—Epirubicin—urinary bladder cancer	0.000207	0.00397	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000207	0.00397	CcSEcCtD
Pitavastatin—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000202	0.00388	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—urinary bladder cancer	0.000201	0.00386	CcSEcCtD
Pitavastatin—ABCG2—lymph node—urinary bladder cancer	0.000201	0.00625	CbGeAlD
Pitavastatin—Dyspepsia—Thiotepa—urinary bladder cancer	0.0002	0.00383	CcSEcCtD
Pitavastatin—Myalgia—Gemcitabine—urinary bladder cancer	0.000199	0.00382	CcSEcCtD
Pitavastatin—Arthralgia—Gemcitabine—urinary bladder cancer	0.000199	0.00382	CcSEcCtD
Pitavastatin—Discomfort—Gemcitabine—urinary bladder cancer	0.000197	0.00377	CcSEcCtD
Pitavastatin—Malaise—Cisplatin—urinary bladder cancer	0.000197	0.00377	CcSEcCtD
Pitavastatin—Myalgia—Fluorouracil—urinary bladder cancer	0.000196	0.00376	CcSEcCtD
Pitavastatin—Fatigue—Thiotepa—urinary bladder cancer	0.000196	0.00375	CcSEcCtD
Pitavastatin—Constipation—Thiotepa—urinary bladder cancer	0.000194	0.00372	CcSEcCtD
Pitavastatin—Discomfort—Fluorouracil—urinary bladder cancer	0.000193	0.00371	CcSEcCtD
Pitavastatin—Back pain—Etoposide—urinary bladder cancer	0.000193	0.00371	CcSEcCtD
Pitavastatin—Muscle spasms—Etoposide—urinary bladder cancer	0.000192	0.00368	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000191	0.00367	CcSEcCtD
Pitavastatin—Confusional state—Fluorouracil—urinary bladder cancer	0.000189	0.00363	CcSEcCtD
Pitavastatin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000187	0.00359	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000186	0.00357	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—urinary bladder cancer	0.000186	0.00357	CcSEcCtD
Pitavastatin—Myalgia—Cisplatin—urinary bladder cancer	0.000186	0.00356	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000186	0.00356	CcSEcCtD
Pitavastatin—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000185	0.00355	CcSEcCtD
Pitavastatin—Discomfort—Cisplatin—urinary bladder cancer	0.000183	0.00352	CcSEcCtD
Pitavastatin—Urticaria—Thiotepa—urinary bladder cancer	0.00018	0.00346	CcSEcCtD
Pitavastatin—Malaise—Etoposide—urinary bladder cancer	0.00018	0.00345	CcSEcCtD
Pitavastatin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000179	0.00344	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000174	0.00334	CcSEcCtD
Pitavastatin—Insomnia—Gemcitabine—urinary bladder cancer	0.000173	0.00331	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—urinary bladder cancer	0.000172	0.0033	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000171	0.00328	CcSEcCtD
Pitavastatin—Insomnia—Fluorouracil—urinary bladder cancer	0.00017	0.00326	CcSEcCtD
Pitavastatin—ABCB1—female reproductive system—urinary bladder cancer	0.000169	0.00527	CbGeAlD
Pitavastatin—Discomfort—Etoposide—urinary bladder cancer	0.000168	0.00322	CcSEcCtD
Pitavastatin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000167	0.00321	CcSEcCtD
Pitavastatin—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000166	0.00319	CcSEcCtD
Pitavastatin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000165	0.00317	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000165	0.00316	CcSEcCtD
Pitavastatin—Fatigue—Gemcitabine—urinary bladder cancer	0.000165	0.00316	CcSEcCtD
Pitavastatin—Confusional state—Etoposide—urinary bladder cancer	0.000164	0.00315	CcSEcCtD
Pitavastatin—Constipation—Gemcitabine—urinary bladder cancer	0.000163	0.00313	CcSEcCtD
Pitavastatin—Asthenia—Thiotepa—urinary bladder cancer	0.000163	0.00312	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000162	0.00311	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—urinary bladder cancer	0.000161	0.00308	CcSEcCtD
Pitavastatin—Pruritus—Thiotepa—urinary bladder cancer	0.000161	0.00308	CcSEcCtD
Pitavastatin—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000158	0.00303	CcSEcCtD
Pitavastatin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000157	0.00302	CcSEcCtD
Pitavastatin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000155	0.00298	CcSEcCtD
Pitavastatin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000155	0.00297	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000154	0.00295	CcSEcCtD
Pitavastatin—ABCB1—vagina—urinary bladder cancer	0.000153	0.00477	CbGeAlD
Pitavastatin—Dizziness—Thiotepa—urinary bladder cancer	0.00015	0.00288	CcSEcCtD
Pitavastatin—Urticaria—Fluorouracil—urinary bladder cancer	0.000149	0.00286	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—urinary bladder cancer	0.000149	0.00285	CcSEcCtD
Pitavastatin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000147	0.00281	CcSEcCtD
Pitavastatin—Rash—Thiotepa—urinary bladder cancer	0.000143	0.00274	CcSEcCtD
Pitavastatin—Dermatitis—Thiotepa—urinary bladder cancer	0.000143	0.00274	CcSEcCtD
Pitavastatin—Headache—Thiotepa—urinary bladder cancer	0.000142	0.00273	CcSEcCtD
Pitavastatin—Fatigue—Etoposide—urinary bladder cancer	0.000141	0.0027	CcSEcCtD
Pitavastatin—Jaundice—Epirubicin—urinary bladder cancer	0.00014	0.00268	CcSEcCtD
Pitavastatin—Constipation—Etoposide—urinary bladder cancer	0.000139	0.00267	CcSEcCtD
Pitavastatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000138	0.00265	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—urinary bladder cancer	0.000137	0.00264	CcSEcCtD
Pitavastatin—Asthenia—Gemcitabine—urinary bladder cancer	0.000137	0.00263	CcSEcCtD
Pitavastatin—Pruritus—Gemcitabine—urinary bladder cancer	0.000135	0.00259	CcSEcCtD
Pitavastatin—Nausea—Thiotepa—urinary bladder cancer	0.000135	0.00259	CcSEcCtD
Pitavastatin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000134	0.00258	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000133	0.00256	CcSEcCtD
Pitavastatin—Pruritus—Fluorouracil—urinary bladder cancer	0.000133	0.00255	CcSEcCtD
Pitavastatin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000131	0.00251	CcSEcCtD
Pitavastatin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000131	0.00251	CcSEcCtD
Pitavastatin—Urticaria—Etoposide—urinary bladder cancer	0.00013	0.00248	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—urinary bladder cancer	0.000129	0.00248	CcSEcCtD
Pitavastatin—Abdominal pain—Etoposide—urinary bladder cancer	0.000129	0.00247	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—urinary bladder cancer	0.000129	0.00247	CcSEcCtD
Pitavastatin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000128	0.00246	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000128	0.00245	CcSEcCtD
Pitavastatin—Asthenia—Cisplatin—urinary bladder cancer	0.000128	0.00245	CcSEcCtD
Pitavastatin—Dizziness—Fluorouracil—urinary bladder cancer	0.000124	0.00238	CcSEcCtD
Pitavastatin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000122	0.00233	CcSEcCtD
Pitavastatin—Rash—Gemcitabine—urinary bladder cancer	0.00012	0.00231	CcSEcCtD
Pitavastatin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00012	0.00231	CcSEcCtD
Pitavastatin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00012	0.0023	CcSEcCtD
Pitavastatin—Headache—Gemcitabine—urinary bladder cancer	0.00012	0.00229	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000119	0.00228	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000118	0.00227	CcSEcCtD
Pitavastatin—Rash—Fluorouracil—urinary bladder cancer	0.000118	0.00227	CcSEcCtD
Pitavastatin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000118	0.00227	CcSEcCtD
Pitavastatin—Headache—Fluorouracil—urinary bladder cancer	0.000118	0.00226	CcSEcCtD
Pitavastatin—Asthenia—Etoposide—urinary bladder cancer	0.000117	0.00224	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—urinary bladder cancer	0.000116	0.00222	CcSEcCtD
Pitavastatin—Pruritus—Etoposide—urinary bladder cancer	0.000115	0.00221	CcSEcCtD
Pitavastatin—Nausea—Gemcitabine—urinary bladder cancer	0.000113	0.00217	CcSEcCtD
Pitavastatin—Rash—Cisplatin—urinary bladder cancer	0.000112	0.00215	CcSEcCtD
Pitavastatin—Dermatitis—Cisplatin—urinary bladder cancer	0.000112	0.00215	CcSEcCtD
Pitavastatin—Diarrhoea—Etoposide—urinary bladder cancer	0.000112	0.00214	CcSEcCtD
Pitavastatin—Nausea—Fluorouracil—urinary bladder cancer	0.000111	0.00214	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000111	0.00213	CcSEcCtD
Pitavastatin—Back pain—Epirubicin—urinary bladder cancer	0.000108	0.00208	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—urinary bladder cancer	0.000108	0.00207	CcSEcCtD
Pitavastatin—Dizziness—Etoposide—urinary bladder cancer	0.000108	0.00207	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000108	0.00206	CcSEcCtD
Pitavastatin—Nausea—Cisplatin—urinary bladder cancer	0.000106	0.00203	CcSEcCtD
Pitavastatin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000104	0.00199	CcSEcCtD
Pitavastatin—Rash—Etoposide—urinary bladder cancer	0.000103	0.00197	CcSEcCtD
Pitavastatin—Dermatitis—Etoposide—urinary bladder cancer	0.000103	0.00197	CcSEcCtD
Pitavastatin—Headache—Etoposide—urinary bladder cancer	0.000102	0.00196	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—urinary bladder cancer	0.000102	0.00195	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—urinary bladder cancer	0.000102	0.00195	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—urinary bladder cancer	0.000101	0.00194	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—urinary bladder cancer	0.000101	0.00193	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—urinary bladder cancer	0.0001	0.00192	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—urinary bladder cancer	9.96e-05	0.00191	CcSEcCtD
Pitavastatin—ABCB1—lymph node—urinary bladder cancer	9.9e-05	0.00308	CbGeAlD
Pitavastatin—Confusional state—Methotrexate—urinary bladder cancer	9.85e-05	0.00189	CcSEcCtD
Pitavastatin—Nausea—Etoposide—urinary bladder cancer	9.68e-05	0.00186	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	9.61e-05	0.00184	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—urinary bladder cancer	9.53e-05	0.00183	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—urinary bladder cancer	9.53e-05	0.00183	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—urinary bladder cancer	9.42e-05	0.00181	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—urinary bladder cancer	9.34e-05	0.00179	CcSEcCtD
Pitavastatin—Confusional state—Epirubicin—urinary bladder cancer	9.21e-05	0.00177	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.9e-05	0.00171	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—urinary bladder cancer	8.83e-05	0.00169	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—urinary bladder cancer	8.82e-05	0.00169	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—urinary bladder cancer	8.82e-05	0.00169	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—urinary bladder cancer	8.71e-05	0.00167	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—urinary bladder cancer	8.6e-05	0.00165	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—urinary bladder cancer	8.53e-05	0.00164	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—urinary bladder cancer	8.42e-05	0.00161	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.33e-05	0.0016	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—urinary bladder cancer	8.26e-05	0.00159	CcSEcCtD
Pitavastatin—Feeling abnormal—Methotrexate—urinary bladder cancer	8.05e-05	0.00154	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—urinary bladder cancer	8.04e-05	0.00154	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	7.98e-05	0.00153	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—urinary bladder cancer	7.88e-05	0.00151	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—urinary bladder cancer	7.81e-05	0.0015	CcSEcCtD
Pitavastatin—Urticaria—Methotrexate—urinary bladder cancer	7.76e-05	0.00149	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—urinary bladder cancer	7.72e-05	0.00148	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.7e-05	0.00148	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—urinary bladder cancer	7.65e-05	0.00147	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—urinary bladder cancer	7.53e-05	0.00144	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.47e-05	0.00143	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—urinary bladder cancer	7.44e-05	0.00143	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—urinary bladder cancer	7.29e-05	0.0014	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—urinary bladder cancer	7.26e-05	0.00139	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—urinary bladder cancer	7.23e-05	0.00139	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—urinary bladder cancer	7.22e-05	0.00139	CcSEcCtD
Pitavastatin—Hypersensitivity—Methotrexate—urinary bladder cancer	7.19e-05	0.00138	CcSEcCtD
Pitavastatin—Asthenia—Methotrexate—urinary bladder cancer	7.01e-05	0.00134	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	6.97e-05	0.00134	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.91e-05	0.00133	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—urinary bladder cancer	6.91e-05	0.00132	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—urinary bladder cancer	6.73e-05	0.00129	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—urinary bladder cancer	6.72e-05	0.00129	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—urinary bladder cancer	6.68e-05	0.00128	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—urinary bladder cancer	6.68e-05	0.00128	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—urinary bladder cancer	6.56e-05	0.00126	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—urinary bladder cancer	6.46e-05	0.00124	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—urinary bladder cancer	6.46e-05	0.00124	CcSEcCtD
Pitavastatin—Diarrhoea—Epirubicin—urinary bladder cancer	6.25e-05	0.0012	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.23e-05	0.00119	CcSEcCtD
Pitavastatin—Rash—Methotrexate—urinary bladder cancer	6.16e-05	0.00118	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—urinary bladder cancer	6.15e-05	0.00118	CcSEcCtD
Pitavastatin—Headache—Methotrexate—urinary bladder cancer	6.12e-05	0.00117	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—urinary bladder cancer	6.07e-05	0.00116	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—urinary bladder cancer	6.04e-05	0.00116	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—urinary bladder cancer	5.98e-05	0.00115	CcSEcCtD
Pitavastatin—Nausea—Methotrexate—urinary bladder cancer	5.8e-05	0.00111	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—urinary bladder cancer	5.78e-05	0.00111	CcSEcCtD
Pitavastatin—Rash—Epirubicin—urinary bladder cancer	5.76e-05	0.0011	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—urinary bladder cancer	5.76e-05	0.0011	CcSEcCtD
Pitavastatin—Headache—Epirubicin—urinary bladder cancer	5.72e-05	0.0011	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—urinary bladder cancer	5.59e-05	0.00107	CcSEcCtD
Pitavastatin—Nausea—Epirubicin—urinary bladder cancer	5.43e-05	0.00104	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—urinary bladder cancer	5.33e-05	0.00102	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—urinary bladder cancer	5.33e-05	0.00102	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—urinary bladder cancer	5.3e-05	0.00102	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—urinary bladder cancer	5.02e-05	0.000963	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	1.78e-05	0.00032	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NCOR1—urinary bladder cancer	1.78e-05	0.000319	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSTM1—urinary bladder cancer	1.78e-05	0.000319	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—UGT2B7—urinary bladder cancer	1.77e-05	0.000318	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.73e-05	0.00031	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NAT2—urinary bladder cancer	1.72e-05	0.000309	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	1.7e-05	0.000306	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GPX1—urinary bladder cancer	1.7e-05	0.000306	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	1.7e-05	0.000305	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	1.7e-05	0.000305	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NAT1—urinary bladder cancer	1.7e-05	0.000305	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	1.68e-05	0.000302	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	1.67e-05	0.0003	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ERCC2—urinary bladder cancer	1.67e-05	0.0003	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.65e-05	0.000296	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NQO1—urinary bladder cancer	1.61e-05	0.000289	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	1.6e-05	0.000288	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	1.6e-05	0.000288	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP4B1—urinary bladder cancer	1.59e-05	0.000286	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	1.58e-05	0.000285	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NAT1—urinary bladder cancer	1.58e-05	0.000285	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTP1—urinary bladder cancer	1.58e-05	0.000283	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—MTHFR—urinary bladder cancer	1.57e-05	0.000282	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PPARG—urinary bladder cancer	1.56e-05	0.000281	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	1.56e-05	0.000281	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.56e-05	0.00028	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	1.55e-05	0.000279	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IFNA2—urinary bladder cancer	1.52e-05	0.000273	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	1.51e-05	0.000272	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.51e-05	0.000271	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC19A1—urinary bladder cancer	1.51e-05	0.000271	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CREBBP—urinary bladder cancer	1.5e-05	0.00027	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000267	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	1.48e-05	0.000267	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	1.48e-05	0.000267	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RRM2—urinary bladder cancer	1.48e-05	0.000267	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	1.48e-05	0.000265	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.48e-05	0.000265	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PRSS3—urinary bladder cancer	1.47e-05	0.000264	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—TYMS—urinary bladder cancer	1.46e-05	0.000263	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	1.45e-05	0.00026	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NCOR1—urinary bladder cancer	1.45e-05	0.00026	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTM1—urinary bladder cancer	1.45e-05	0.00026	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.44e-05	0.000259	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	1.44e-05	0.000259	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.44e-05	0.000258	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.43e-05	0.000258	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	1.42e-05	0.000256	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.42e-05	0.000255	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	1.4e-05	0.000251	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	1.39e-05	0.00025	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GPX1—urinary bladder cancer	1.39e-05	0.000249	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	1.38e-05	0.000248	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HPGDS—urinary bladder cancer	1.37e-05	0.000247	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ENO2—urinary bladder cancer	1.37e-05	0.000247	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000245	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000245	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ERCC2—urinary bladder cancer	1.36e-05	0.000245	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.35e-05	0.000242	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	1.34e-05	0.000241	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTT1—urinary bladder cancer	1.33e-05	0.00024	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	1.32e-05	0.000237	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	1.31e-05	0.000235	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	1.31e-05	0.000235	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.3e-05	0.000235	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.29e-05	0.000231	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000231	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—MTHFR—urinary bladder cancer	1.28e-05	0.00023	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PPARG—urinary bladder cancer	1.27e-05	0.000229	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.26e-05	0.000226	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.25e-05	0.000224	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.25e-05	0.000224	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.23e-05	0.000221	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.23e-05	0.000221	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.23e-05	0.000221	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—urinary bladder cancer	1.23e-05	0.000221	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CREBBP—urinary bladder cancer	1.22e-05	0.00022	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.22e-05	0.000219	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.21e-05	0.000218	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	1.21e-05	0.000217	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.2e-05	0.000216	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	1.2e-05	0.000215	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.18e-05	0.000213	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.18e-05	0.000212	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.18e-05	0.000212	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.18e-05	0.000211	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TYMP—urinary bladder cancer	1.17e-05	0.000211	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.16e-05	0.000209	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.16e-05	0.000208	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.16e-05	0.000208	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.14e-05	0.000205	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.13e-05	0.000204	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.13e-05	0.000202	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.13e-05	0.000202	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NQO1—urinary bladder cancer	1.11e-05	0.000199	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	1.09e-05	0.000196	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLAU—urinary bladder cancer	1.08e-05	0.000194	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTEN—urinary bladder cancer	1.07e-05	0.000193	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.07e-05	0.000192	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NAT2—urinary bladder cancer	1.06e-05	0.000191	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPARG—urinary bladder cancer	1.04e-05	0.000187	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.03e-05	0.000185	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—EP300—urinary bladder cancer	1.02e-05	0.000184	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.01e-05	0.000182	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.01e-05	0.000181	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—urinary bladder cancer	1e-05	0.00018	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	9.98e-06	0.000179	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	9.97e-06	0.000179	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	9.86e-06	0.000177	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	9.78e-06	0.000176	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.65e-06	0.000173	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.63e-06	0.000173	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	9.6e-06	0.000173	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	9.39e-06	0.000169	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	9.39e-06	0.000169	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	9.32e-06	0.000167	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NAT2—urinary bladder cancer	9.29e-06	0.000167	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	9.28e-06	0.000167	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—urinary bladder cancer	9.24e-06	0.000166	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.22e-06	0.000166	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	9.21e-06	0.000165	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	9.17e-06	0.000165	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	9.17e-06	0.000165	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RRM2—urinary bladder cancer	9.16e-06	0.000165	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CREBBP—urinary bladder cancer	8.89e-06	0.00016	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—urinary bladder cancer	8.82e-06	0.000159	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IGF1—urinary bladder cancer	8.78e-06	0.000158	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	8.78e-06	0.000158	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—urinary bladder cancer	8.73e-06	0.000157	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	8.68e-06	0.000156	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	8.62e-06	0.000155	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TYMS—urinary bladder cancer	8.59e-06	0.000154	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	8.53e-06	0.000153	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	8.53e-06	0.000153	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—urinary bladder cancer	8.49e-06	0.000153	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NCOR1—urinary bladder cancer	8.49e-06	0.000153	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO2—urinary bladder cancer	8.48e-06	0.000152	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HPGDS—urinary bladder cancer	8.48e-06	0.000152	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.48e-06	0.000152	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	8.48e-06	0.000152	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.43e-06	0.000152	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—EP300—urinary bladder cancer	8.33e-06	0.00015	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	8.28e-06	0.000149	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	8.27e-06	0.000149	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTT1—urinary bladder cancer	8.22e-06	0.000148	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	8.16e-06	0.000147	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.14e-06	0.000146	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GPX1—urinary bladder cancer	8.13e-06	0.000146	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	8.1e-06	0.000146	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.1e-06	0.000146	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RHOA—urinary bladder cancer	8.05e-06	0.000145	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RRM2—urinary bladder cancer	8.02e-06	0.000144	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ERCC2—urinary bladder cancer	7.98e-06	0.000143	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.7e-06	0.000138	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	7.69e-06	0.000138	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—urinary bladder cancer	7.5e-06	0.000135	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	7.49e-06	0.000135	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO2—urinary bladder cancer	7.43e-06	0.000134	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	7.43e-06	0.000134	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	7.21e-06	0.00013	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—urinary bladder cancer	7.12e-06	0.000128	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	6.94e-06	0.000125	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	6.94e-06	0.000125	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	6.94e-06	0.000125	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.9e-06	0.000124	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	6.87e-06	0.000124	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NQO1—urinary bladder cancer	6.83e-06	0.000123	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—EP300—urinary bladder cancer	6.79e-06	0.000122	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—urinary bladder cancer	6.75e-06	0.000121	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.75e-06	0.000121	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	6.73e-06	0.000121	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	6.71e-06	0.000121	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.67e-06	0.00012	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.63e-06	0.000119	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.63e-06	0.000119	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	6.57e-06	0.000118	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	6.4e-06	0.000115	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	6.31e-06	0.000113	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—urinary bladder cancer	6.08e-06	0.000109	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EP300—urinary bladder cancer	6.06e-06	0.000109	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—urinary bladder cancer	6.05e-06	0.000109	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NQO1—urinary bladder cancer	5.99e-06	0.000108	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SRC—urinary bladder cancer	5.89e-06	0.000106	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CREBBP—urinary bladder cancer	5.84e-06	0.000105	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.82e-06	0.000105	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.78e-06	0.000104	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—EP300—urinary bladder cancer	5.77e-06	0.000104	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	5.73e-06	0.000103	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—urinary bladder cancer	5.7e-06	0.000102	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	5.59e-06	0.000101	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.55e-06	9.97e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.52e-06	9.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.43e-06	9.76e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	5.33e-06	9.58e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TYMS—urinary bladder cancer	5.3e-06	9.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	5.27e-06	9.47e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	5.27e-06	9.47e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—urinary bladder cancer	5.24e-06	9.41e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NCOR1—urinary bladder cancer	5.24e-06	9.41e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	5.17e-06	9.29e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	5.05e-06	9.07e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPX1—urinary bladder cancer	5.02e-06	9.02e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	4.99e-06	8.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	4.95e-06	8.9e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ERCC2—urinary bladder cancer	4.93e-06	8.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—urinary bladder cancer	4.88e-06	8.77e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—urinary bladder cancer	4.79e-06	8.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.73e-06	8.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.67e-06	8.39e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	4.66e-06	8.37e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TYMS—urinary bladder cancer	4.64e-06	8.35e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—urinary bladder cancer	4.63e-06	8.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	4.59e-06	8.25e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	4.59e-06	8.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.51e-06	8.11e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	4.51e-06	8.1e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPX1—urinary bladder cancer	4.4e-06	7.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	4.34e-06	7.8e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—urinary bladder cancer	4.34e-06	7.79e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	4.32e-06	7.76e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	4.3e-06	7.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	4.29e-06	7.71e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	4.29e-06	7.71e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—urinary bladder cancer	4.17e-06	7.5e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—urinary bladder cancer	4.15e-06	7.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.11e-06	7.38e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	4.06e-06	7.29e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.03e-06	7.25e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—EP300—urinary bladder cancer	3.98e-06	7.15e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.79e-06	6.81e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—urinary bladder cancer	3.75e-06	6.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.63e-06	6.52e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CREBBP—urinary bladder cancer	3.61e-06	6.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—urinary bladder cancer	3.29e-06	5.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	3.16e-06	5.68e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.07e-06	5.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.97e-06	5.34e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—urinary bladder cancer	2.95e-06	5.31e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.95e-06	5.31e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.59e-06	4.66e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.59e-06	4.65e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—urinary bladder cancer	2.58e-06	4.63e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.47e-06	4.44e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—EP300—urinary bladder cancer	2.46e-06	4.41e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.42e-06	4.34e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.26e-06	4.06e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—EP300—urinary bladder cancer	2.15e-06	3.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.11e-06	3.79e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.01e-06	3.61e-05	CbGpPWpGaD
